Skip to content

To keep going please Log in.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Sign up.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MGRX Mangoceuticals, Inc. Common Stock
$2.13 -1.47% -0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MGRX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 22.8M
Enterprise value 22.6M
Trailing PE -0.42355370915626
PEG Ratio 0.0097611434320377
Enterprise to EBITDA -2.719
Enterprise to revenue 44.2
Price to book MRQ 0.72335917
Price to sales TTM 44.54106

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-03-31
Revenue (TTM) 511.1K
EBITDA -8309112
Diluted EPS TTM -4.63
Total Cash (MRQ) 76496
Current ratio (MRQ) 0.118
Operating Cash Flow (TTM) -6147426

MGRX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent MGRX News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.